Compare AbCellera Biologics Inc (ABCL) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Weibo Corp — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and Weibo Corp pays a 7.75% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | WB | |
|---|---|---|
Market Cap | $2.99B | $1.93B |
Sector | Health | Media |
52-Week High | $9.76 | $12.83 |
52-Week Low | $2.78 | $7.20 |
Enterprise Value | $2.58B | $1.20B |
Dividend Yield | — | 7.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
